Detalles de la búsqueda
1.
Transient production of receptor-binding domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice.
Mol Biol Rep
; 49(7): 6113-6123, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35526244
2.
In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI-MS spectrum.
Anal Bioanal Chem
; 413(30): 7559-7585, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34739558
3.
Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19.
PLoS One
; 18(9): e0288006, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37751460
4.
Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.
Pharmaceuticals (Basel)
; 16(9)2023 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37765106
5.
Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate.
Vaccines (Basel)
; 10(6)2022 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35746505
Resultados
1 -
5
de 5
1
Próxima >
>>